查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957350

2026年全球體外肺部模型市場報告

In-Vitro Lung Model Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體外肺模型市場發展迅速。預計該市場規模將從2025年的5.4億美元成長到2026年的6.5億美元，複合年成長率達21.0%。這一成長歸因於多種因素，例如動物模型在呼吸系統研究中的局限性、2D肺細胞培養技術的長期應用、呼吸系統疾病研究活動的增加、學術界肺生物學研究的發展以及基於類器官的研究方法的早期應用。

預計未來幾年體外肺模型市場將快速成長，到2030年將達到12.9億美元，複合年成長率（CAGR）為18.6%。預測期內的成長要素包括：對可預測的臨床前肺模型的需求不斷成長；人們越來越重視減少動物試驗；呼吸系統藥物開發平臺不斷擴展；對先進體外研究工具的投資增加；以及對更俱生理相關性的肺部疾病模型的需求。預測期內的主要趨勢包括：藥物研究中3D肺模型的應用日益廣泛；肺晶片平台在疾病建模中的應用日益廣泛；對高度人體相關的體外肺測試系統的需求日益成長；體外肺模型在毒理學和安全性測試中的應用日益廣泛；以及體外肺模型在臨床前研究管線中的整合程度不斷提高。

預計未來幾年，體外肺模型市場的成長將主要受臨床研究增加的推動。臨床研究旨在評估新型醫療程序、藥物和診斷工具在人體內的安全性、有效性和療效。由於醫療需求不斷成長、對先進醫療療法的需求日益增加，以及為複雜疾病開發創新解決方案的持續努力，臨床研究的數量正在增加。體外肺模型市場透過提供一個受控系統來支持臨床研究，有助於藥物篩檢、毒性評估、疾病建模以及肺部特異性生物反應的評估。例如，根據美國臨床試驗註冊網站ClinicalTrials.gov的數據，截至2024年1月，全球註冊的臨床試驗數量預計到2023年底將達到477,230項，高於2022年的437,508項。因此，臨床研究的增加正在推動體外肺模型市場的成長。

體外肺模型市場的主要企業正致力於開發先進的3D（3D）呼吸組織模型，以提高生理相關性、增強預測準確性並強化臨床前試驗能力。 3D呼吸組織模型是實驗室設計的3D結構，由在模擬人體呼吸道組織結構和功能的條件下培養的原代或特化呼吸細胞構成，包括粘液分泌、纖毛活動和屏障功能的完整性。例如，2023年4月，美國生物技術公司MatTek Corporation宣布推出“EpiNasal”，這是一種由人類原代鼻上皮細胞開發的3D呼吸組織模型。該模型模擬了鼻上皮的關鍵特徵，例如杯狀細胞、功能性緊密連接和運動纖毛，為研究人員提供了一個高度相關的平台，用於研究藥物、化學物質、病原體和消費品對人體呼吸組織的影響。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球體外肺模型市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 藥物研究中3D肺模型的應用日益增多
    • 擴大晶片肺平台在疾病建模的應用
    • 人們越來越傾向於選擇與人體相關的體外肺部測試系統。
    • 擴大體外肺模型在毒理學和安全性測試的應用
    • 加強體外肺模型在非臨床研究流程的整合。

第5章 終端用戶產業市場分析

  • 學術研究機構
  • 製藥公司
  • 生技公司
  • 合約研究組織（CRO）
  • 政府研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球體外肺模型市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球體外肺模型市場規模、比較及成長率分析
  • 全球體外肺模型市場表現：規模與成長，2020-2025年
  • 全球體外肺模型市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按類型
  • 2D模型、3D模型
  • 透過使用
  • 藥物發現與毒理學研究、生理學研究、3D（3D）模型開發及其他應用。
  • 最終用戶
  • 學術研究機構、製藥和生物技術公司以及其他最終用戶
  • 按類型細分：2D (2D) 模型
  • 單層細胞培養、共培養
  • 按類型細分：3D (3D) 模型
  • 球狀體、類器官、晶片肺模型

第10章 區域與國別分析

  • 全球體外肺模型市場：按地區分類，實際結果和預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球體外肺模型市場：依國家分類，實際結果及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 體外肺模型市場：競爭格局及市場佔有率（2024年）
  • 體外肺模型市場：公司估值矩陣
  • 體外肺模型市場：公司概況
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • PerkinElmer Inc.
    • Charles River Laboratories International Inc.
    • Epithelix

第37章 其他大型企業和創新企業

  • STEMCELL Technologies, American Type Culture Collection（ATCC）, BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical KK, 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年體外肺模型市場：提供新機會的國家
  • 2030年體外肺模型市場：新興細分市場機會
  • 2030年體外肺部模型市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH3MIVLM01_G26Q1

An in vitro lung model is a laboratory-based scientific system designed to replicate the cellular, structural, and functional characteristics of the human lung under controlled conditions. These models allow researchers to study disease progression, identify biomarkers, and evaluate the effectiveness of treatments. They serve as valuable tools for advancing the understanding of lung biology, supporting therapy development, and improving overall health outcomes.

The main types of in vitro lung models include two-dimensional (2D) models and three-dimensional (3D) models. A 2D model is a simplified representation of lung cells and tissues cultured on a flat surface and is commonly used in basic research and early-stage substance testing. These models are applied across various areas such as drug discovery, toxicology studies, physiological research, three-dimensional (3D) model development, and others, and are utilized by academic research institutes, pharmaceutical and biotechnology companies, and other end users.

Tariffs have impacted the in-vitro lung model market by increasing the cost of imported microfluidic components, laboratory instruments, and specialized cell culture materials used in advanced lung model systems. These effects have been most evident in lung-on-a-chip and three-dimensional model segments, particularly in North America and Europe where high-precision components are often sourced internationally. Asia-Pacific markets have experienced procurement delays due to trade dependencies. However, tariffs have encouraged regional manufacturing of research equipment and localized sourcing of consumables, supporting long-term supply chain resilience.

The in-vitro lung model market research report is one of a series of new reports from The Business Research Company that provides in-vitro lung model market statistics, including in-vitro lung model industry global market size, regional shares, competitors with a in-vitro lung model market share, detailed in-vitro lung model market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro lung model industry. This in-vitro lung model market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro lung model market size has grown exponentially in recent years. It will grow from $0.54 billion in 2025 to $0.65 billion in 2026 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to limitations of animal models in respiratory research, longstanding use of two-dimensional lung cell cultures, increasing respiratory disease research activity, growth in academic lung biology research, early adoption of organoid-based research methods.

The in-vitro lung model market size is expected to see rapid growth in the next few years. It will grow to $1.29 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to rising demand for predictive preclinical lung models, increasing focus on reducing animal testing, expansion of respiratory drug development pipelines, growing investment in advanced in-vitro research tools, demand for more physiologically relevant lung disease models. Major trends in the forecast period include increasing adoption of three-dimensional lung models in drug research, growing use of lung-on-a-chip platforms for disease modeling, rising preference for human-relevant in-vitro lung testing systems, expansion of in-vitro lung models in toxicology and safety studies, greater integration of in-vitro lung models in preclinical research pipelines.

The growing number of clinical studies is expected to drive the growth of the in vitro lung model market in the coming years. Clinical studies are research investigations carried out to assess the safety, efficacy, and outcomes of new medical treatments, drugs, or diagnostic tools in humans. The volume of clinical studies is increasing due to rising healthcare demands, greater need for advanced medical therapies, and ongoing efforts to develop innovative solutions for complex health conditions. The in vitro lung model market supports clinical research by providing controlled systems that facilitate drug screening, toxicity assessment, disease modeling, and the evaluation of lung-specific biological responses. For example, in January 2024, according to ClinicalTrials.gov, a US-based clinical trial registry, there were 477,230 registered clinical trials worldwide by the end of 2023, up from 437,508 trials in 2022. Therefore, the rise in clinical studies is contributing to the growth of the in vitro lung model market.

Major companies operating in the in vitro lung model market are concentrating on the development of advanced three-dimensional (3D) respiratory tissue models to enhance physiological relevance, improve predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model is a laboratory-engineered, three-dimensional structure composed of primary or specialized respiratory cells cultured under conditions that replicate the structure and function of human airway tissues, including mucus secretion, ciliary activity, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, launched EpiNasal, a 3D respiratory tissue model developed from primary human nasal epithelial cells. This model reproduces key features of nasal epithelium such as goblet cells, functional tight junctions, and motile cilia, offering researchers a highly relevant platform to study the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

In July 2024, Tergus Pharma, a US-based end-to-end service provider for topical pharmaceutical products, merged with MedPharm Ltd. for an undisclosed amount. This merger enhances Tergus Pharma's integrated development and manufacturing capabilities by combining MedPharm's strengths in formulation development, in vitro performance testing, and human tissue-based delivery models with Tergus's expertise in commercial manufacturing and serialization. It also expands the company's capacity to develop and manufacture hormone-based and highly potent drugs through increased GMP capabilities at its Durham, North Carolina facility. MedPharm Ltd. is a UK-based company that provides in vitro models simulating lung and nasal drug-delivery systems.

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro lung model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro lung model market consists of revenue earned by providing services such as customization services, training and education services, medical education, healthcare training, forensic science, repair and maintenance services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-vitro lung model models market also includes sales of anatomical organ models, muscle models, human skeleton models, anatomical charts, and posters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Lung Model Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in-vitro lung model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro lung model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in-vitro lung model market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Two-Dimensional (2D) Model; Three-Dimensional (3D) Model
  • 2) By Application: Drug Discovery And Toxicology Studies; Physiological Research; Three-Dimensional (3D) Model Development; Other Applications
  • 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures; Co-cultures
  • 2) By Three-Dimensional (3D) Model: Spheroids; Organoids; Lung-On-A-chip Models
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; PerkinElmer Inc.; Charles River Laboratories International Inc.; Epithelix; STEMCELL Technologies; American Type Culture Collection (ATCC); BioIVT; InSphero; Emulate Inc.; PhoenixBio Co. Ltd.; Newcells Biotech; CN Bio Innovations Ltd.; Mimetas; Cyfuse Biomedical K.K.; 3D Biotek LLC; AlveoliX AG; Hesperos Inc.; SynVivo Inc.; VITROCELL Systems GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. In-Vitro Lung Model Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global In-Vitro Lung Model Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. In-Vitro Lung Model Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global In-Vitro Lung Model Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Three-Dimensional Lung Models In Drug Research
    • 4.2.2 Growing Use Of Lung-On-A-Chip Platforms For Disease Modeling
    • 4.2.3 Rising Preference For Human-Relevant In-Vitro Lung Testing Systems
    • 4.2.4 Expansion Of In-Vitro Lung Models In Toxicology And Safety Studies
    • 4.2.5 Greater Integration Of In-Vitro Lung Models In Preclinical Research Pipelines

5. In-Vitro Lung Model Market Analysis Of End Use Industries

  • 5.1 Academic Research Institutes
  • 5.2 Pharmaceutical Companies
  • 5.3 Biotechnology Companies
  • 5.4 Contract Research Organizations (Cros)
  • 5.5 Government Research Laboratories

6. In-Vitro Lung Model Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In-Vitro Lung Model Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global In-Vitro Lung Model PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global In-Vitro Lung Model Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global In-Vitro Lung Model Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global In-Vitro Lung Model Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In-Vitro Lung Model Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In-Vitro Lung Model Market Segmentation

  • 9.1. Global In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
  • 9.2. Global In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
  • 9.3. Global In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
  • 9.4. Global In-Vitro Lung Model Market, Sub-Segmentation Of Two-Dimensional (2D) Model, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Monolayer Cell Cultures, Co-cultures
  • 9.5. Global In-Vitro Lung Model Market, Sub-Segmentation Of Three-Dimensional (3D) Model, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spheroids, Organoids, Lung-On-A-chip Models

10. In-Vitro Lung Model Market Regional And Country Analysis

  • 10.1. Global In-Vitro Lung Model Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global In-Vitro Lung Model Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In-Vitro Lung Model Market

  • 11.1. Asia-Pacific In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In-Vitro Lung Model Market

  • 12.1. China In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In-Vitro Lung Model Market

  • 13.1. India In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In-Vitro Lung Model Market

  • 14.1. Japan In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In-Vitro Lung Model Market

  • 15.1. Australia In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In-Vitro Lung Model Market

  • 16.1. Indonesia In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In-Vitro Lung Model Market

  • 17.1. South Korea In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan In-Vitro Lung Model Market

  • 18.1. Taiwan In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia In-Vitro Lung Model Market

  • 19.1. South East Asia In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe In-Vitro Lung Model Market

  • 20.1. Western Europe In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK In-Vitro Lung Model Market

  • 21.1. UK In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany In-Vitro Lung Model Market

  • 22.1. Germany In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France In-Vitro Lung Model Market

  • 23.1. France In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy In-Vitro Lung Model Market

  • 24.1. Italy In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain In-Vitro Lung Model Market

  • 25.1. Spain In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe In-Vitro Lung Model Market

  • 26.1. Eastern Europe In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia In-Vitro Lung Model Market

  • 27.1. Russia In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America In-Vitro Lung Model Market

  • 28.1. North America In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA In-Vitro Lung Model Market

  • 29.1. USA In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada In-Vitro Lung Model Market

  • 30.1. Canada In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America In-Vitro Lung Model Market

  • 31.1. South America In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil In-Vitro Lung Model Market

  • 32.1. Brazil In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East In-Vitro Lung Model Market

  • 33.1. Middle East In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa In-Vitro Lung Model Market

  • 34.1. Africa In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. In-Vitro Lung Model Market Regulatory and Investment Landscape

36. In-Vitro Lung Model Market Competitive Landscape And Company Profiles

  • 36.1. In-Vitro Lung Model Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. In-Vitro Lung Model Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. In-Vitro Lung Model Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Epithelix Overview, Products and Services, Strategy and Financial Analysis

37. In-Vitro Lung Model Market Other Major And Innovative Companies

  • STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

38. Global In-Vitro Lung Model Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The In-Vitro Lung Model Market

40. In-Vitro Lung Model Market High Potential Countries, Segments and Strategies

  • 40.1 In-Vitro Lung Model Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 In-Vitro Lung Model Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 In-Vitro Lung Model Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer